Superparamagnetic Iron Oxide Nanoparticle–Aptamer Bioconjugates for Combined Prostate Cancer Imaging and Therapy

This publication has 40 references indexed in Scilit:

• Thermally Cross-Linked Superparamagnetic Iron Oxide Nanoparticles: Synthesis and Application as a Dual Imaging Probe for Cancer in Vivo
  Journal of the American Chemical Society, 2007
• Quantum Dot−Aptamer Conjugates for Synchronous Cancer Imaging, Therapy, and Sensing of Drug Delivery Based on Bi-Fluorescence Resonance Energy Transfer
  Nano Letters, 2007
• ErbB receptors: from oncogenes to targeted cancer therapies
  Journal of Clinical Investigation, 2007
• Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo
  Proceedings of the National Academy of Sciences, 2006
• Frontline therapy with rituximab added to the combination of cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) significantly improves the outcome for patients with advanced-stage follicular lymphoma compared with therapy with CHOP alone: results of a prospective randomized study of the German Low-Grade Lymphoma Study Group
  Blood, 2005
• Trastuzumab after Adjuvant Chemotherapy in HER2-Positive Breast Cancer
  New England Journal of Medicine, 2005
• Sensitive, Noninvasive Detection of Lymph Node Metastases
  PLoS Medicine, 2004
• PET and [18F]-FDG in oncology: A clinical update
  Nuclear Medicine and Biology, 1996
• Detection and characterization of the prostate‐specific membrane antigen (PSMA) in tissue extracts and body fluids
  International Journal of Cancer, 1995
• Original Articles: Prostate Cancer: The Use and Accuracy of Cross-Sectional Imaging and Fine Needle Aspiration Cytology for Detection of Pelvic Lymph Node Metastases Before Radical Prostatectomy
  Journal of Urology, 1995